Showing results 2 to 4 of 4
Issue Date | Title | Journal Title |
---|---|---|
2024 | Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial | NATURE COMMUNICATIONS |
2021 | PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma | BMC CANCER |
2021 | Prognostic implications of PD-L1 expression in patients with angiosarcoma | FUTURE SCIENCE OA |